Media mogul Ben Nicholls has been accepted into Forbes Business Council, Business News
Business News

Media mogul Ben Nicholls has been accepted into Forbes Business Council, Business News

Business new tamfitronics Ben Nicholls, co-founder of JamPrime, a PR and communications firm, has been accepted into Forbes Business Council – an invitation-only community for successful business owners and leaders.London, England, United Kingdom - September 11, 2024 — Ben Nicholls, co-founder of JamPrime, a PR and communications firm, has been accepted into Forbes Business Council – an invitation-only community for successful business owners and leaders.The 39-year-old entrepreneur, who is from London, was selected by a review committee based on the depth and diversity of his experience in the media industry.Criteria for acceptance includes a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honours.Ben, who is also the co-founder of the UK-based news agency, Jam Press – which he started alongside his wife and business partner Jody...
Continue reading
Helicap Closes Largest Credit Facility Yet with Xendit’s XenCapital: USD$50 Million to Empower Southeast Asian Businesses, Business News
Business News

Helicap Closes Largest Credit Facility Yet with Xendit’s XenCapital: USD$50 Million to Empower Southeast Asian Businesses, Business News

Business new tamfitronics /PRNewswire/ -- Helicap, a leading fintech platform provider specialising in emerging markets, is proud to announce the successful facilitation of a credit facility with XenCapital, the lending arm of Xendit, a fintech unicorn with operations across Southeast Asia and which has raised US$515million in venture capital funding. Digital lending has been the most active Southeast Asian fintech subsector in 2023, seeing growth in 2024 and projected to grow another 33% in 2025 .XenCapital has demonstrated its merchants in the lending space, having disbursed over USD$700 million in loans to businesses across Southeast Asia since its inception in 2021. Its success underscores its robust...
Continue reading
M&M, Pidilite, Dr Reddy’s deny Congress charge, say no preferential treatment received from Sebi
Business News

M&M, Pidilite, Dr Reddy’s deny Congress charge, say no preferential treatment received from Sebi

Business new tamfitronics MUMBAI: Dismissing allegations of irregularities, three listed companies - Mahindra & Mahindra, Pidilite Industries and Dr Reddy's Laboratories - said they had availed supply chain and leadership coaching services from Dhaval Bookhusband of Sebi chief Madhabi Puri Buch and director of Agora Advisory, which is in the midst of a controversy involving conflict of interest charges.M&M said it hired Dhaval in 2019 after he retired from Unilever as its chief procurement officer. The company said he was currently on the board of its subsidiary Bristlecon, adding that his compensation was "specifically and only for his expertise on supply chain". M&M didn't define the quantum of compensation paid to Dhaval. It also didn't comment on the separate payment made to Agora.Congress claimed Sebi, while Madhabi was its whole-time member, approved and settled...
Continue reading
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing, Business News
Business News

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing, Business News

Business new tamfitronics The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months BOSTON and ROLLE, Switzerland, Sept. 10, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new milestone in the global introduction of the liquid biopsy test MSK-ACCESS® powered with SOPHiA DDM™, first announced in October 2023. Under a definitive partnership agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), SOPHiA GENETICS will accelerate the deployment of MSK-ACCESS® powered with SOPHiA DDM™ to 20 locations worldwide over the next 12 months. Liquid biopsy testing offers a complementary alternative...
Continue reading